Dr. Bradley Shapiro, a gastroenterologist with Duly Health and Care, has been named a 2026 Castle Connolly Top Doctor, marking the second consecutive year he has received this prestigious designation. Only 7 percent of the nation's licensed physicians are selected annually as Castle Connolly Top Doctors for their specialties in their respective regions.
Dr. Shapiro has been an integral part of Duly Health and Care since September 2017, providing specialized gastrointestinal care to the suburban Chicago community for over two decades. His medical practice focuses on evaluating and treating a wide range of primary gastrointestinal conditions, including esophageal and swallowing disorders such as GERD, Barrett's esophagus, and eosinophilic esophagitis, as well as colorectal screening and surveillance. He also addresses complex digestive issues including Crohn's disease and ulcerative colitis.
As a specialist in gastroenterology, Dr. Shapiro performs several key diagnostic and therapeutic procedures including colonoscopy with polyp resection, upper endoscopy (EGD), dilation for esophageal strictures, and esophageal pH and motility studies. His approach to patient care emphasizes evidence-based medicine delivered with genuine compassion, utilizing a shared decision-making process to build personalized treatment plans.
Dr. Shapiro's extensive medical training began at the University of Michigan, where he earned his Bachelor of Science with distinction in 1986, followed by his medical degree from the University of Michigan Medical School in 1990. He completed his internal medicine internship at Northwestern Memorial Hospital in 1991, followed by his internal medicine residency at Rush University Medical Center from 1991 to 1993, where he later served as a Clinical Instructor of Internal Medicine. His advanced specialized training included a Gastroenterology Fellowship at The Cleveland Clinic Foundation, where he served as Chief Fellow.
Throughout his career, Dr. Shapiro has made significant contributions to medical research and academia. He is a published author in several peer-reviewed journals, including the American Journal of Gastroenterology and Modern Pathology, with specific research emphasis on p53 suppressor gene mutations as markers for cancer in ulcerative colitis. He has been a diplomate of the National Board of Medical Examiners since 1991 and holds board certifications in Gastroenterology and Internal Medicine. His professional excellence has been recognized with numerous honors, including the American College of Gastroenterology Research Grant and several Vitals Compassionate Doctor awards.
Castle Connolly publishes its Top Doctors list at https://www.castleconnolly.com and in various print and online partner publications. The selection process involves nominations by peer physicians and evaluation by the physician-led Castle Connolly research team based on criteria including medical education, training, hospital appointments, and disciplinary histories. Doctors cannot pay to be selected as Castle Connolly Top Doctors, ensuring the integrity of the recognition process.
For business and technology leaders monitoring healthcare innovation, Dr. Shapiro's recognition highlights the importance of specialized medical expertise in advancing patient care standards. His research focus on genetic markers for cancer in ulcerative colitis represents the intersection of medical science and technological advancement in diagnostic precision. The Castle Connolly selection process itself demonstrates how peer validation and rigorous evaluation criteria can establish quality benchmarks in professional services, a model that could inform talent recognition systems across industries.
